Total submissions: 2
| Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
|---|---|---|---|---|---|---|---|---|
| Labcorp Genetics |
RCV002958809 | SCV003279343 | benign | not provided | 2024-11-07 | criteria provided, single submitter | clinical testing | |
| Ambry Genetics | RCV004068203 | SCV004899380 | uncertain significance | Inborn genetic diseases | 2021-09-16 | criteria provided, single submitter | clinical testing | The c.4062G>C (p.K1354N) alteration is located in exon 19 (coding exon 19) of the LRP6 gene. This alteration results from a G to C substitution at nucleotide position 4062, causing the lysine (K) at amino acid position 1354 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |